Skip to Main Content

Paper Details

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
bioRxiv
3
2021
Author NameAffiliation
Larissa B ThackrayWashington University in St. Louis
Michael S DiamondWashington University in St. Louis
Michael S DiamondWashington University in St. Louis
Michael S DiamondWashington University in St. Louis
Siyuan DingWashington University in St. Louis
  • 1 - 5

Datasets

Release 1.2